Yuriy I. Abramov

Yuriy I. Abramov

Auto-generated profile, based on publicly available information

Yuriy I. Abramov

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2022 in The Russian Archives of Internal Medicine
Verified
Journal Article
Open access
PDF file
AKA. Yu. Kraposhina
A. Yu. Kraposhina
ESE. A. Sobko
E. A. Sobko
IDIrina V. Demko
Irina V. Demko
AKA. B. Katser
A. B. Katser
OKO. V. Kazmerchuk
O. V. Kazmerchuk
YAYu. I. Abramov
Yu. I. Abramov
Современное представление о тяжелой бронхиальной астме

15 March 2021 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
AKAngelina Yu. Kraposhina
Angelina Yu. Kraposhina
ESElena A. Sobko
Elena A. Sobko
IDIrina V. Demko
Irina V. Demko
AKAnna B. Kacer
Anna B. Kacer
OKOlga V. Kazmerchuk
Olga V. Kazmerchuk
YAYuriy I. Abramov
Yuriy I. Abramov
The review provides data on one of the phenotypes of severe bronchial asthma it is asthma with fixed airway obstruction. According to data published today, there is no single pathway for the formation of fixed airway obstruction in patients with severe asthma. Increasing knowledge of the pathophysiology of fixed airway obstruction, as well as identifying the most significant risk factors, is essential for the successful treatment of such patients. In addition, the development of fixed obstruction is associated with a worse and sometimes fatal prognosis. Expanding the existing views is also necessary to overcome the difficulties of differential diagnosis between bronchial asthma with fixed airway obstruction and bronchial asthma in combination with COPD. All this will optimize the approach to the management of patients with bronchial asthma to prevent the formation of fixed airway obstruction.

15 October 2022 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
AKA. Yu. Kraposhina
A. Yu. Kraposhina
ESE. А. Sobko
E. А. Sobko
IDIrina V. Demko
Irina V. Demko
OKO. V. Kazmerchuk
O. V. Kazmerchuk
AKA. B. Kacer
A. B. Kacer
YAYu. I. Abramov
Yu. I. Abramov
To date, the study of the role of proteases in the pathogenesis of various diseases remains relevant. The variety of cathepsin functions is associated with the peculiarities of their localization, expression, and regulation, due to which cathepsins are involved in development of many pathologies. Dysregulation of proteases, their inhibitors, and substrates can lead to the development of multiple organ dysfunction.The review presents data on the characteristics of the entire family of cathepsins and cathepsin S, in particular. The pathophysiological role of cathepsin S in the formation of bronchopulmonary pathologies, as well as in bronchial asthma is described, and intraand extracellular implementation mechanisms are considered. The authors believe it is this enzyme that could be targeted in targeted asthma therapy to prevent airway wall remodeling at the earliest stages of the disease. The literature search was carried out in the search engines Medline, eLibrary, Scopus, the Cochrane Library, and RSCI.

13 April 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
IDIrina V. Demko
Irina V. Demko
ЕСЕ. А. Собко
Е. А. Собко
АKА. Yu. Kraposhina
А. Yu. Kraposhina
AKA. B. Katser
A. B. Katser
KSKsenia Shadrina
Ksenia Shadrina
YKYu. A. Khramova
Yu. A. Khramova
The review analyzes the role of microRNAs in the pathogenesis of bronchopulmonary diseases. The universality of the mechanisms underlying epigenetics causes a continuously growing interest in research in this field in various fields of medicine. Research in the field of epigenetics not only allows us to expand knowledge in the field of etiology and pathogenesis, but also helps to explain the heterogeneity of the disease. Currently, biomarkers used in determining the phenotype of bronchial asthma or COPD are not able to display the variety of pathological processes involved in the pathogenesis of the disease at the molecular level. It is noteworthy that microRNAs retain their stability in various body environments, are resistant to high temperatures, pH fluctuations, and freeze-thaw cycles, which greatly simplifies the process of detecting these molecules in biological fluids. The amount of detected microRNA is highly specific for a particular pathological process occurring intracellularly. Currently, biomarkers used in determining the phenotype of bronchial asthma or chronic obstructive pulmonary disease are not able to reflect the variety of pathological processes involved in the pathogenesis of the disease at the molecular level. For both diseases, the key links are known to be inflammation, airway remodeling, and an abnormal response of epithelial cells to external stimuli. Thus, there is a great potential for using microRNAs in clinical practice: as noninvasive biomarkers reflecting key points of pathogenesis, as a prognostic biomarker predicting response to therapy, and possibly in the future as new therapeutic targets.

1 January 2022 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
AKA.YU. Kraposhina
A.YU. Kraposhina
ESE.A. Sobko
E.A. Sobko
IDI.V. Demko
I.V. Demko
AKA.B. Katser
A.B. Katser
OKO.V. Kazmerchuk
O.V. Kazmerchuk
YAYu.I. Abramov
Yu.I. Abramov
В статье приведены данные, отражающие значение немедикаментозных факторов в достижении контроля над бронхиальной астмой (БА). Известно, что <50% больных БА достигают контроля, а несоблюдение режима терапии ассоциировано со снижением показателей функции внешнего дыхания, частыми обострениями, ухудшением качества жизни, частыми обращениями за медицинской помощью, потерей трудоспособности, а также является причиной 80% всех случаев смерти от астмы. Контроль над заболеванием, приверженность лечению и качество жизни являются тесно переплетенными понятиями, но их изучение представляет определенные трудности вследствие субъективизма существующих методов. Однако правильная оценка и учет данных, полученных при изучении личностных особенностей пациента, могут внести неоценимый вклад в разработку стратегий по повышению эффективности лечения, что имеет непосредственное влияние на исход заболевания.

27 August 2025 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
VMV.A. Mosina
V.A. Mosina
GMG.V. Matyushin
G.V. Matyushin
EBE.A. Bykhanova
E.A. Bykhanova
ARA.E. Ryazanov
A.E. Ryazanov
NLN.V. Litvinyuk
N.V. Litvinyuk
YAYu.I. Abramov
Yu.I. Abramov
Vasospastic angina pectoris is characterized by an anginal attack arising from a reversible spasm of the coronary arteries. Sudden cessation of the blood flow can lead to myocardial ischemia, myocardial infarction and sudden cardiac death. Some studies suggest that coronary arteries’ spasm is associated with myocarditis. Objective. To demonstrate a rare clinical case of variant angina pectoris development in presence of acute myocarditis in a young woman. Case report. Patient, 41 years old, was admitted with complaints of a paroxysmal pressing retrosternal pain with radiation to the back, cough during a pain attack with blood expectoration, dyspnea at rest, feeling short of breath. Pulmonary artery thromboembolism, pneumonia, acute myocardial infarction were excluded. Attacks of retrosternal pain were accompanied by transient changes on the electrocardiogram, coronary spasm has been proven in coronary angiography. «Myocarditis» diagnosis was confirmed by MRI. Conclusion. The importance of performing precise differential diagnosis in patients with anginal pain has been shown. The possible development of coronary arteries spasm in presence of acute myocarditis must be taken into consideration.